中文
|
English
Home
|
Help
|
Contact
Return
Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
10.3350/cmh.2020.0042
Author:
Ju Hyun SHIM
1
Author Information
1. Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Publication Type:
Editorial
From:
Clinical and Molecular Hepatology 2020;26(2):183-184
Country
Republic of Korea
Language:
0